(AVHHL - AVITA MEDICAL INC)

company profile

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Avita Medical Cdi (AVHHL) is trading at 0.99185

Open Price
0.99185
Previous close
0.99185
Previous close
0.99185
P/E Ratio
0
Sector
Health Care
Shares outstanding
86482440
Primary exchange
OTC Markets
ISIN
AU000000AVH4